증권 기록 · 과거 분기 (아카이브)
NVO
Novo Nordisk A/S · Healthcare · Drug Manufacturers - General
19추적 보유자
-1Δ 보유자
80.89M보유 주식 수
$4.49B보고 가치
+2신규 편입 포지션
−3청산
모멘텀 입력값 (비교 가능한 운용사):
보유자 폭 -5.0% ·
주식 흐름 -2.8% ·
순 신규 포지션 -5.3%
— 산식
광범위한 분산 — 주식 수 감소 및 보유자 수 축소
모든 소유권 수치: 추적 대상 13F 운용사 한정, 보통주 포지션, 보고 기간 Q3 2025
시계열 보유 현황
| 분기 | 보유자 | Δ | 주식 수 | 보고 가치 | 신규 | 청산 |
|---|---|---|---|---|---|---|
| Q2 2026 | 134 | +1 | 236.29M | $11.33B | +13 | −12 |
| Q1 2026 | 134 | -8 | 242.80M | $8.91B | +5 | −13 |
| Q4 2025 | 140 | +1 | 228.46M | $11.63B | +3 | −2 |
| Q3 2025 | 19 | -1 | 80.89M | $4.49B | +2 | −3 |
| Q2 2025 | 17 | -1 | 53.30M | $3.68B | +1 | −2 |
| Q1 2025 | 16 | 0 | 43.10M | $3.00B | — | — |
| Q4 2024 | 16 | -1 | 48.20M | $4.15B | +1 | −2 |
| Q3 2024 | 16 | -1 | 43.13M | $5.09B | +1 | −2 |
| Q2 2024 | 17 | — | 46.04M | $6.57B | — | — |
보유 현황 · Q3 2025
| # | 운용사 | 주식 수 | Δ 주식 수 | 가치 | 비중 | 보유 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 14.08M | +1.0% | $781.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 14.08M | +1.0% | $781.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 14.08M | +1.0% | $781.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 14.08M | +1.0% | $781.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Fidelity (FMR) ✦ | 14.08M | +1.0% | $781.04M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 12.41M | — | $688.82M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 10.82M | — | $600.22M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | Fisher Asset Management ✦ | 10.32M | -6.2% | $572.82M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 53 | Goldman Sachs Group ✦ | 6.72M | — | $372.69M | 0.1% | n/c | 1 | SEC ↗ |
| 54 | Goldman Sachs Group ✦ | 6.72M | — | $372.69M | 0.1% | n/c | 1 | SEC ↗ |
| 55 | Goldman Sachs Group ✦ | 6.72M | — | $372.69M | 0.1% | n/c | 1 | SEC ↗ |
| 56 | State Street Global Advisors ✦ (패시브) | 6.11M | +1.0% | $340.12M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 57 | T. Rowe Price ✦ | 4.85M | -21.8% | $269.24M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 58 | BlackRock ✦ (패시브) | 3.96M | -9.1% | $219.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 59 | BlackRock ✦ (패시브) | 3.96M | -9.1% | $219.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 60 | BlackRock ✦ (패시브) | 3.96M | -9.1% | $219.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 61 | BlackRock ✦ (패시브) | 3.96M | -9.1% | $219.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 62 | BlackRock ✦ (패시브) | 3.96M | -9.1% | $219.95M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 63 | Citadel Advisors ✦ | 3.13M | +690.0% | $173.80M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 64 | Citadel Advisors ✦ | 3.13M | +690.0% | $173.80M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 65 | Renaissance Technologies ✦ | 2.88M | -41.6% | $159.92M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 66 | Markel Group ✦ | 2.37M | +4.9% | $131.44M | 1.1% | ▲ Add | 6 | SEC ↗ |
| 67 | Markel Group ✦ | 2.37M | +4.9% | $131.44M | 1.1% | ▲ Add | 6 | SEC ↗ |
| 68 | Two Sigma Investments ✦ | 1.69M | -23.7% | $93.86M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 69 | D. E. Shaw & Co. ✦ | 1.05M | 신규 | $58.24M | 0.1% | New | 1 | SEC ↗ |
| 70 | Capital World Investors ✦ | 210.86K | -2.2% | $11.70M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 71 | Bridgewater Associates ✦ | 138.95K | 신규 | $7.71M | 0.0% | New | 1 | SEC ↗ |
| 72 | AQR Capital Management ✦ | 123.80K | -1.3% | $6.87M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 73 | AQR Capital Management ✦ | 123.80K | -1.3% | $6.87M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 74 | AQR Capital Management ✦ | 123.80K | -1.3% | $6.87M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 75 | Millennium Management ✦ | 23.90K | -33.0% | $1.33M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 76 | GAMCO Investors ✦ | 4.14K | -8.8% | $229,951 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 77 | Baillie Gifford ✦ | 314 | +141.5% | $17,424 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 78 | Baillie Gifford ✦ | 314 | +141.5% | $17,424 | 0.0% | ▲ Add | 6 | SEC ↗ |
"해당 운용사 비중" = 해당 운용사의 신고된 13F 주식 가치 대비 포지션 비중 — 확신도 지표. ✦ = 선별 운용사.
신규 매수자
| D. E. Shaw & Co. | $58.24M | 0.1% |
| Bridgewater Associates | $7.71M | 0.0% |
청산됨
| Tiger Global Management | $87.59M | 이었음 0.3% |
| Wellington Management | $17.99M | 이었음 0.0% |
| Marshall Wace | $2.15M | 이었음 0.0% |
전체 시장 맥락: 전체 13F 공시 기관 기준 (SEC 구조화 데이터, Q1 2026): 1 보유 기관, 1.21M 주식, $43.09M 신고 기준. 이는 위의 추적 유니버스 수치와 다른 이전 기간으로, 두 수치는 절대 혼용되지 않습니다.
공동 보유 빈도 높음
이 증권의 추적 보유자들이 가장 많이 함께 보유하는 종목 — 기본적 관계가 아닌 공동 보유 건수 기준.
출처: 파싱된 13F 보통주 포지션 기반 보유 현황(추적 유니버스, 변동 비교 세트); 내부자 행은 Form 3/4/5에서; 지분은 Schedule 13D/13G에서 수집; 모든 공시는 SEC EDGAR 원문으로 연결됩니다.
보고 기간: Q3 2025 ·
방법론 ·
API를 통해 조회